Zak Mir talks to Dr Tom Becker, CEO & President, Iofina, as the specialists in the exploration and production of iodine and manufacturers of specialty chemical products, announce audited full-year results for the 12 months to 31 December 2024. The company revealed higher sales of iodine derivatives and increased iodine production driving 9% revenue growth: Revenue of $54.5m (2023: $50.0m); Seventh successive year of revenue growth.
